Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» November 2010
November 2010
Trophos and MS-Repair partners present promising data on novel approach in multiple sclerosis at SfN meeting
Trophos and MS-Repair partners present promising data on novel approach in multiple sclerosis at SfN meeting
Pharmabiz
Trophos SA
MS-Repair
Olesoxime
multiple sclerosis
Drug Maker Cited on Quality Issues
Drug Maker Cited on Quality Issues
NY Times
JNJ
Gilead: Preventing HIV Infection With a Pill
Gilead: Preventing HIV Infection With a Pill
Seeking Alpha
Gilead Sciences
HIV
Truvada
Promising Data Puts Exelixis Back on Track
Promising Data Puts Exelixis Back on Track
Seeking Alpha
Exelixis
XL184
cancer
Merck's Risky Bet on Heart Drugs May Yield Pills with Lipitor-Like Success
Merck's Risky Bet on Heart Drugs May Yield Pills with Lipitor-Like Success
Bloomberg
Merck
Pfizer
CETP inhibitors
Merck KGaA Says FDA Extends Review of MS Pill in Setback Against Novartis
Merck KGaA Says FDA Extends Review of MS Pill in Setback Against Novartis
Bloomberg
Merck KGaA
FDA
MS
multiple sclerosis
Novartis
Darmstadt
Termeer Touts Campath-Linked CVRs
Termeer Touts Campath-Linked CVRs
InVivo
Henri Termeer
Campath
MS
Genzyme
multiple sclerosis
Sanofi
A $58M Loss: A Pfizer Prempro Appeal Is Denied
A $58M Loss: A Pfizer Prempro Appeal Is Denied
Pharmalot
Pfizer
Wyeth
HRT
Prempro
appeals
Can Genzyme Make $3.5B a Year Giving Away a Drug for Free?
Can Genzyme Make $3.5B a Year Giving Away a Drug for Free?
BNET Pharma
Genzyme
alemtuzumab
Sanofi
MS
multiple sclerosis
Don't Get Too Worked Up Over Gilead's Earnings
Don't Get Too Worked Up Over Gilead's Earnings
Motley Fool
Gilead Sciences
earnings
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »